TC Biopharm (TCBPW) News Today $0.01 0.00 (-16.86%) As of 02/21/2025 02:43 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period TC BioPharm completes dosing in Cohort A of Phase IIb trial for AMLFebruary 15, 2025 | msn.comTC BioPharm reports progress in AML treatment trialFebruary 11, 2025 | msn.comTC Biopharm plans to begin Proof of Concept preclinical studies for TCB008January 15, 2025 | msn.comTC Biopharm advances negotiations with acquisition candidatesDecember 31, 2024 | markets.businessinsider.comTC Biopharm files $100M mixed securities shelfNovember 27, 2024 | markets.businessinsider.comTC Biopharm awarded funding of $250,000 from G-Rex Grant ProgramNovember 13, 2024 | markets.businessinsider.comTC BioPharm Isn't at Risk of Delisting, Company SaysOctober 25, 2024 | marketwatch.comTC BioPharm Refutes Rumors Of Delisting From Nasdaq, Confirms Compliance With Nasdaq RequirementsOctober 25, 2024 | markets.businessinsider.comBioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Newly Opened London-Based ACHIEVE UK Trial Site Amid ‘Very Positive’ Study ProgressionSeptember 25, 2024 | msn.comInvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Marks Milestone as First Patient Completes Full Dose in ACHIEVE Trial with No Adverse EventsSeptember 12, 2024 | msn.comTC BioPharm: TCBP Announces Plan to Implement ADS Ratio ChangeAugust 3, 2024 | finanznachrichten.deTC BioPharm adjusts ADS to ordinary share ratioAugust 3, 2024 | investing.comLatest News for TC BioPharm (Holdings) Stock (NASDAQ:TCBP)May 7, 2024 | benzinga.comTC BioPharm regains compliance with NasdaqJanuary 4, 2024 | msn.comTC BioPharm Shares Drop After Half of Workforce Gets CutJanuary 3, 2024 | marketwatch.comTC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline EfficienciesJanuary 3, 2024 | finance.yahoo.comTC BioPharm Shares Tumble After Offering Gets PricedDecember 19, 2023 | marketwatch.comTrading was temporarily halted for "TCBPW" at 07:12 PM with a stated reason of "News pending."December 15, 2023 | marketbeat.comTC Biopharm plans to implement ADS ratio changeDecember 13, 2023 | msn.comTC BioPharm Announces Plan to Implement ADS Ratio ChangeDecember 13, 2023 | finance.yahoo.comTC BioPharm receives FDA approval for AML cell therapy trialNovember 28, 2023 | msn.comTC BioPharm Inks Trial-Management Deal With Fortrea Amid Cost CuttingNovember 2, 2023 | marketwatch.comTC BioPharm Announces Streamlined Efficiencies and Reduces Overhead with Selection of Single Global CRO for Clinical TrialsNovember 2, 2023 | finance.yahoo.comADRs End Higher; TC Biopharm PLC Climbs 19%October 30, 2023 | morningstar.comTC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial RequirementsOctober 25, 2023 | finance.yahoo.comTC BioPharm Announces Filing Of IND For TCB-008 - Quick FactsOctober 23, 2023 | markets.businessinsider.comTC BioPharm Announces Submission of Investigational New Drug (IND) Application to U.S. FDA for Treatment of Relapse/Refractory AMLOctober 23, 2023 | finance.yahoo.comTC Biopharm (Holdings) Plc (TCBPW)October 12, 2023 | finance.yahoo.comTC BioPharm to Present at the LD Micro Main Event XVISeptember 27, 2023 | finance.yahoo.comTC BioPharm Maintains Nasdaq ListingJuly 31, 2023 | finance.yahoo.comTC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day PodcastJuly 6, 2023 | finance.yahoo.comTC BioPharm to Present at LD Micro Invitational XIII Conference on June 7, 2023May 24, 2023 | finance.yahoo.comTC BioPharm Announces Closing of $5.5 Million Public OfferingMarch 30, 2023 | finance.yahoo.comADRs End Higher, Ambev and TC BioPharm Trade HigherMarch 28, 2023 | morningstar.comTC BioPharm Announces Pricing of $5.5 Million Public OfferingMarch 28, 2023 | finance.yahoo.comTC BioPharm Unveils Corporate Restructuring Plan; To Cut Up To 30% Of WorkforceMarch 22, 2023 | markets.businessinsider.comTC Biopharm Announces Corporate Restructuring, Reduction in OverheadMarch 22, 2023 | finance.yahoo.comTC BioPharm Shifts Focus to FDA Clinical TrialsMarch 7, 2023 | finance.yahoo.comTC BioPharm Announces Dr. Mike Leek as Chief Technology OfficerFebruary 23, 2023 | finance.yahoo.comTC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell TherapiesFebruary 21, 2023 | finance.yahoo.comTC BioPharm Announces New Chair of the Board, Arlene MorrisFebruary 14, 2023 | finance.yahoo.comTC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety CohortFebruary 7, 2023 | finance.yahoo.comTC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical DivisionJanuary 30, 2023 | finance.yahoo.comTC Biopharm Shares Drop 13% After Nasdaq Non-Compliance NoticeJanuary 20, 2023 | marketwatch.comTC BioPharm to Host Shareholder Update CallJanuary 20, 2023 | finance.yahoo.comFinancialnewsmedia.com: Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical TrialsJanuary 19, 2023 | finanznachrichten.deTC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1)January 19, 2023 | finance.yahoo.comTC BioPharm Announces Closing of $7.35 Million Private PlacementNovember 30, 2022 | finance.yahoo.comTC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid LeukemiaNovember 22, 2022 | finance.yahoo.comTC BioPharm to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceAugust 22, 2022 | finance.yahoo.com Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address TCBPW Media Mentions By Week TCBPW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCBPW News Sentiment▼0.000.60▲Average Medical News Sentiment TCBPW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCBPW Articles This Week▼00▲TCBPW Articles Average Week Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BriaCell Therapeutics News Today Eloxx Pharmaceuticals News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Lexaria Bioscience News Today Rocket Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCBPW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
